Bartholomew, Erin
Chung, Bo-Young
Davis, Mitchell
Yeroushalmi, Samuel
Chung, Mimi
Hakimi, Marwa
Bhutani, Tina
Liao, Wilson http://orcid.org/0000-0001-7883-6439
Article History
Received: 20 July 2023
Accepted: 11 August 2023
First Online: 7 September 2023
Declarations
:
: Informed consent was obtained under UCSF IRB approval protocol: 20-32273.
: Dr. Wilson Liao, MD has received research funding from Abbvie, Amgen, Janssen, Leo, Novartis, Pfizer, Regeneron, and TRex Bio. Tina Bhutani is a principal investigator for trials sponsored by Abbvie, Castle, CorEvitas, Dermavant, Galderma, Mindera, and Pfizer. She has received research grant funding from Novartis and Regeneron. She has been an advisor for Abbvie, Arcutis, Boehringer Ingelheim, Bristol Myers Squibb, Janssen, Leo, Lilly, Novartis, Pfizer, Sun, and UCB. The remaining authors declare no conflicts of interest.